Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 129, Issue 16
April 20 2017
Issue Cover

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Efficacy in the margins of NHL with ibrutinib
Clinical Trials & Observations
Paul M. Barr
View Articletitled, Efficacy in the margins of NHL with ibrutinib
INSIDE BLOOD COMMENTARY
Multiple myeloma cells sent “PAKing”!
Paola Neri,Nizar J. Bahlis
View Articletitled, Multiple myeloma cells sent “PAKing”!
INSIDE BLOOD COMMENTARY
Anti-CD20-IL-21 fusokine: the tail wags the dog
Stephen M. Ansell
View Articletitled, Anti-CD20-IL-21 fusokine: the tail wags the dog
INSIDE BLOOD COMMENTARY
I am SAMD9L: 7q regulator I am
Matthew Collin
View Articletitled, I am <em>SAMD9L</em>: 7q regulator I am
INSIDE BLOOD COMMENTARY
Making thrombolysis safer in stroke
David Gailani
View Articletitled, Making thrombolysis safer in stroke
INSIDE BLOOD COMMENTARY
Complement and clot
Vahid Afshar-Kharghan
View Articletitled, Complement and clot

REVIEW ARTICLE

Mouse models of MLL leukemia: recapitulating the human disease
Thomas A. Milne
View Articletitled, Mouse models of MLL leukemia: recapitulating the human disease

CLINICAL TRIALS AND OBSERVATIONS

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
Clinical Trials & Observations
Ariela Noy,Sven de Vos,Catherine Thieblemont,Peter Martin,Christopher R. Flowers,Franck Morschhauser,Graham P. Collins,Shuo Ma,Morton Coleman,Shachar Peles,Stephen Smith,Jacqueline C. Barrientos,Alina Smith,Brian Munneke,Isaiah Dimery,Darrin M. Beaupre,Robert Chen
View Articletitled, Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma
Supplemental data

LYMPHOID NEOPLASIA

Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma
Mariateresa Fulciniti,Joaquin Martinez-Lopez,William Senapedis,Stefania Oliva,Rajya Lakshmi Bandi,Nicola Amodio,Yan Xu,Raphael Szalat,Annamaria Gulla,Mehmet K. Samur,Aldo Roccaro,Maria Linares,Michele Cea,Erkan Baloglu,Christian Argueta,Yosef Landesman,Sharon Shacham,Siyuan Liu,Monica Schenone,Shiaw-Lin Wu,Barry Karger,Rao Prabhala,Kenneth C. Anderson,Nikhil C. Munshi
View Articletitled, Functional role and therapeutic targeting of p21-activated kinase 4 in multiple myeloma
Supplemental data
Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell–dependent cytotoxicity
Shruti Bhatt,Salma Parvin,Yu Zhang,Hyun-Mi Cho,Kranthi Kunkalla,Francisco Vega,John M. Timmerman,Seung-Uon Shin,Joseph D. Rosenblatt,Izidore S. Lossos
View Articletitled, Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell–dependent cytotoxicity
Supplemental data
Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines
CME
Frederika A. van Nimwegen,Georgios Ntentas,Sarah C. Darby,Michael Schaapveld,Michael Hauptmann,Pieternella J. Lugtenburg,Cecile P. M. Janus,Laurien Daniels,Flora E. van Leeuwen,David J. Cutter,Berthe M. P. Aleman
View Articletitled, Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines
Supplemental data

MYELOID NEOPLASIA

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms
Bianca Tesi,Josef Davidsson,Matthias Voss,Elisa Rahikkala,Tim D. Holmes,Samuel C. C. Chiang,Jonna Komulainen-Ebrahim,Sorina Gorcenco,Alexandra Rundberg Nilsson,Tim Ripperger,Hannaleena Kokkonen,David Bryder,Thoas Fioretos,Jan-Inge Henter,Merja Möttönen,Riitta Niinimäki,Lars Nilsson,Cornelis Jan Pronk,Andreas Puschmann,Hong Qian,Johanna Uusimaa,Jukka Moilanen,Ulf Tedgård,Jörg Cammenga,Yenan T. Bryceson
View Articletitled, Gain-of-function <em>SAMD9L</em> mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms
Supplemental data

THROMBOSIS AND HEMOSTASIS

Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke
Fabrício Simão,Tuna Ustunkaya,Allen C. Clermont,Edward P. Feener
View Articletitled, Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke
Supplemental data
Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development
Saravanan Subramaniam,Kerstin Jurk,Lukas Hobohm,Sven Jäckel,Mona Saffarzadeh,Kathrin Schwierczek,Philip Wenzel,Florian Langer,Christoph Reinhardt,Wolfram Ruf
View Articletitled, Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development
Supplemental data
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations
Brief Report
Alessio Branchini,Mattia Ferrarese,Matteo Campioni,Giancarlo Castaman,Rosella Mari,Francesco Bernardi,Mirko Pinotti
View Articletitled, Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations

TRANSPLANTATION

Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study
Clinical Trials & Observations
Parinda A. Mehta,Stella M. Davies,Thomas Leemhuis,Kasiani Myers,Nancy A. Kernan,Susan E. Prockop,Andromachi Scaradavou,Richard J. O’Reilly,David A. Williams,Leslie Lehmann,Eva Guinan,David Margolis,K. Scott Baker,Adam Lane,Farid Boulad
View Articletitled, Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study
The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality
Joshua A. Hill,Bryan T. Mayer,Hu Xie,Wendy M. Leisenring,Meei-Li Huang,Terry Stevens-Ayers,Filippo Milano,Colleen Delaney,Mohamed L. Sorror,Brenda M. Sandmaier,Garrett Nichols,Danielle M. Zerr,Keith R. Jerome,Joshua T. Schiffer,Michael Boeckh
View Articletitled, The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality
Supplemental data

LETTERS TO BLOOD

Published abstracts at international meetings often over- or underestimate the initial response rate
Clinical Trials & Observations
Ofrat Beyar-Katz,Jacob M. Rowe,Lauren E. Townsend,Martin S. Tallman,Rivka Hadomi,Netanel A. Horowitz
View Articletitled, Published abstracts at international meetings often over- or underestimate the initial response rate
Supplemental data
Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial
Clinical Trials & Observations
Pier Luigi Zinzani,Cinzia Pellegrini,Annalisa Chiappella,Alice Di Rocco,Flavia Salvi,Maria Giuseppina Cabras,Lisa Argnani,Vittorio Stefoni
View Articletitled, Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial
Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia
Colin D. Godwin,George B. McDonald,Roland B. Walter
View Articletitled, Sinusoidal obstruction syndrome following CD33-targeted therapy in acute myeloid leukemia

BLOOD WORK

MDS with isolated del(5q) and internuclear bridging
Zhaodong Xu,Jean McGowan-Jordan
View Articletitled, MDS with isolated del(5q) and internuclear bridging

CONTINUING MEDICAL EDUCATION (CME) QUESTIONS

Risk of heart failure following Hodgkin lymphoma
CME
View Articletitled, Risk of heart failure following Hodgkin lymphoma
All Issues

Advertisement intended for health care professionals

A belt-and-suspenders approach to PNH
Appreciating the oral microbiome’s impact on GVHD
Oral pathogens exacerbate chronic GVHD
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease
Surface pTα expression predicts LCK activation and preclinical synergy of LCK and JAK coinhibition in adult T-ALL

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals